Rosedale Woman Pleads Guilty to Conspiracy to Distribute Controlled Substances and Money Laundering

Baltimore, Maryland – Terry Allen, 57, of Rosedale, Maryland, has pleaded guilty to conspiracy to distribute controlled substances and money laundering.

Kelly O. Hayes, U.S. Attorney for the District of Maryland, announced the guilty plea with Acting Special Agent in Charge Amanda M. Koldjeski, Federal Bureau of Investigation (FBI) – Baltimore Field Office; Special Agent in Charge Ibrar A. Mian, Drug Enforcement Administration (DEA) – Washington Division; Special Agent in Charge Maureen Dixon, Health and Human Services-Office of the Inspector General (HHS-OIG) – Philadelphia Regional Office; and Chief Robert O. McCullough, Baltimore County Police Department (BCPD).

According to the guilty plea, in 2022, during an investigation into a target, the FBI discovered that the target paid Allen more than $270,000.  Agents later learned that Allen was supplying the FBI target with diverted prescription drugs. As a result, the FBI partnered with the DEA and identified Allen as the leader of a Baltimore-region drug trafficking organization (DTO).  Agents soon learned that from 2022 to 2023, Allen’s DTO flooded the Baltimore community with thousands of diverted oxycodone pills.

The DTO’s members deployed a vast network of pseudo-patients to acquire diverted oxycodone pills.  Pseudo patients are individuals recruited by drug traffickers to enter “pill-mill” clinics with fictitious complaints of pain to receive prescriptions for Schedule II controlled substances.  As part of the conspiracy, pseudo-patients gave their oxycodone prescriptions to DTO members in exchange for cash payments or oxycodone.

In February 2023, law enforcement received court authorization to intercept phone calls and text messages from numerous DTO members’ cellular phones.  Intercepted calls revealed that Allen was distributing vast quantities of oxycodone.

On these calls, Allen openly discussed the large quantity of drugs she possessed for redistribution. She acquired her vast supply of oxycodone from her large pseudo-patient network.  Intercepted calls revealed how Allen and her top oxycodone supplier, Co-Conspirator 1, collaborated to manage the pseudo-patients.  Co-Conspirator 1 managed 12 pseudo-patients to acquire oxycodone, which Co-Conspirator 1 then resold to Allen.  During their intercepted calls, Allen and Co-Conspirator 1 discussed inventory; transferred pseudo-patients to pill-mill clinics that would easily refill oxycodone prescriptions or give higher dosages; and arranged for pseudo-patients to pass urine screenings.

Additionally, through the investigation, law enforcement uncovered Allen’s money laundering.  A review of Allen’s bank records revealed she received and spent more than $2 million from 2017 to 2023.  Agents traced Allen’s drug transactions through peer-to-peer applications such as Zelle and Cash App.

In May 2023, agents obtained more than 30 search warrants for residences, vehicles, and persons involved in the investigation.  On May 31, agents searched Allen’s residence, located in Rosedale, Maryland.  As law enforcement searched Allen’s house, she agreed to speak with FBI agents in a separate room. Allen then admitted to using pseudo-patients to acquire oxycodone that she redistributed on the street.

During the search, agents found approximately $39,380; drug ledgers; a calendar with annotations regarding medical appointments for pseudo-patients; distribution quantity of oxycodone pills, suboxone strips, and Adderall pills; a Glock 19 9mm handgun; and a Remington 12-gauge shotgun.  The money and firearms were connected to Allen’s drug trafficking activities.

Authorities arrested Allen, but after her bail hearing, she was released on home detention. In August 2023, while on home detention, law enforcement learned that Allen was distributing oxycodone.  On September 13, law enforcement searched her home and found two pseudo-patients’ prescription-pill bottles, containing 200 oxycodone 20MG pills.

During the investigation, agents obtained Maryland Prescription Drug Monitoring Program (PDMP) records for all of the DTO’s pseudo-patients’ oxycodone prescriptions.  According to PDMP records, members of the conspiracy illegally re-distributed at least 3,000 kilograms of converted drug weight worth of oxycodone.

Through the conspiracy, Allen sold approximately 4,454 pills, containing 30 milligrams of oxycodone for $45 per pill; approximately 12,835 pills, containing 20 milligrams of oxycodone for $30 per pill; approximately 6,749 pills, containing 15 milligrams of oxycodone for $20 per pill; and approximately 770 pills, containing 30 milligrams of Adderall for $20 per pill.  Allen received approximately $735,860 from selling the pills. In addition to using her residence in Rosedale to distribute drugs, Allen leveraged the proceeds from her drug trafficking activities to pay the mortgage for the property.

Allen faces a maximum of 40 years in prison followed by up to lifetime of supervised release for conspiracy to distribute controlled substances and money laundering. Sentencing is scheduled for August 26, at 10:00 a.m.

This case is part of an Organized Crime Drug Enforcement Task Forces (OCDETF) investigation.  OCDETF identifies, disrupts, and dismantles the highest-level drug traffickers, money launderers, gangs, and transnational criminal organizations that threaten the United States by using a prosecutor-led, intelligence-driven, multi-agency approach that leverages the strengths of federal, state, and local law enforcement agencies against criminal networks.

U.S. Attorney Hayes commended the FBI, DEA, HHS-OIG, and BCPD for their work in the investigation.  Ms. Hayes also thanked Assistant U.S. Attorneys Calvin C. Miner and Ari D. Evans who are prosecuting the federal case.

For more information about the Maryland U.S. Attorney’s Office, its priorities, and resources available to help the community, please visit justice.gov/usao-md and justice.gov/usao-md/community-outreach.

# # #